Overview

Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis

Status:
Terminated

Trial end date:
2008-01-01

Target enrollment:

Participant gender:

Summary

This is a clinical study organized to collect clinical data to better define the activity of some antimicrobials already marketed in Italy and in the rest of the world for the treatment of acute bacterial rhinosinusitis

Phase:

Phase 4

Details

Lead Sponsor:

Bayer

Treatments:

Amoxicillin
Amoxicillin-Potassium Clavulanate Combination
Clavulanic Acid
Clavulanic Acids
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination